Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World
NCT ID: NCT02310880
Last Updated: 2015-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
35 participants
OBSERVATIONAL
2010-09-30
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality-Base Intelligent Orientation and Mobility Specialists Trial
NCT04639531
Factors in Learning And Plasticity: Healthy Vision
NCT05439759
Eye Movement Rehabilitation in Low Vision Patients
NCT04929756
Virtual Reality Mobility Training System for Veterans With Vision Loss
NCT00333879
Assessment and Training Visio Spatial Neglect in a Virtual Reality Environment
NCT02258789
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low vision (virtual street training)
Low vision subjects trained in virtual streets and observed in real streets
No interventions assigned to this group
Low vision (real street training)
Low vision subjects trained in real streets and observed in real streets
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants with central field loss should have best corrected binocular visual acuity between 20/200 and 20/1000, but with relatively intact peripheral visual field (\>80o).
* Participants with peripheral visual field loss should have \>20/63 visual acuity and no more than 20 deg diameter but not less than 8 deg diameter visual field in the better eye.
Exclusion Criteria
* Previous or current recipient of O\&M training.
* Participants who have plans to receive O\&M training during the study period.
* Age younger than 19 or older than 81.
* Significant cognitive impairment as determined with the Short Portable Mental Status Questionnaire (≥2 errors); inability to understand and speak English.
* Severe hearing impairment that interferes with interactions with O\&M specialists.
* Inability or unwillingness to make visits required by the study.
* Not living in the Birmingham-Jefferson county area.
* Persons who have a history of epilepsy or who are prone to motion sickness or simulator aftereffect, determined by an epileptic seizure history inquiry and a Motion Sickness History Questionnaire.
19 Years
81 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lei Liu, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Clinical Eye Research Facility
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
X100716003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.